Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TMEM156 mRNA | CTD | PMID:32741896 | 17beta-estradiol 3-benzoate | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TMEM156 mRNA | CTD | PMID:32741896 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TMEM156 mRNA | CTD | PMID:20106945 more ... | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TMEM156 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | TMEM156 (Homo sapiens) | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of TMEM156 mRNA | CTD | PMID:29704546 | 2-palmitoylglycerol | increases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of TMEM156 mRNA | CTD | PMID:37199045 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | TMEM156 (Homo sapiens) | 6480464 | [bisphenol S co-treated with Fulvestrant] results in increased methylation of TMEM156 gene | CTD | PMID:31601247 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of TMEM156 mRNA | CTD | PMID:31881176 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of TMEM156 mRNA | CTD | PMID:28959563 | aflatoxin B1 | increases methylation | ISO | TMEM156 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of TMEM156 intron | CTD | PMID:30157460 | aflatoxin B1 | increases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of TMEM156 mRNA | CTD | PMID:32234424 | all-trans-retinoic acid | increases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of TMEM156 mRNA | CTD | PMID:33167477 | alpha-Zearalanol | increases expression | EXP | | 6480464 | Zeranol results in increased expression of TMEM156 mRNA | CTD | PMID:35163327 | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of TMEM156 mRNA | CTD | PMID:30779732 | benzo[a]pyrene | increases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of TMEM156 mRNA | CTD | PMID:22178795 and PMID:32234424 | benzo[a]pyrene | affects methylation | ISO | TMEM156 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of TMEM156 intron | CTD | PMID:30157460 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of TMEM156 mRNA | CTD | PMID:25181051 | calcitriol | increases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of TMEM156 mRNA | CTD | PMID:16002434 | copper atom | multiple interactions | ISO | TMEM156 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of TMEM156 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | TMEM156 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of TMEM156 mRNA | CTD | PMID:20971185 | crocidolite asbestos | increases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | Asbestos and Crocidolite results in increased expression of TMEM156 mRNA | CTD | PMID:18687144 | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of TMEM156 mRNA | CTD | PMID:27523638 | cyclosporin A | decreases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of TMEM156 mRNA | CTD | PMID:27989131 | Didecyldimethylammonium | increases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | didecyldimethylammonium results in increased expression of TMEM156 mRNA | CTD | PMID:32763356 | dimethylarsinic acid | multiple interactions | ISO | Tmem156 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TMEM156 mRNA | CTD | PMID:34876320 | dioxygen | multiple interactions | EXP | | 6480464 | [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of TMEM156 mRNA | CTD | PMID:33729688 | disodium selenite | increases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | Sodium Selenite results in increased expression of TMEM156 mRNA | CTD | PMID:24383545 | doxorubicin | affects response to substance | ISO | TMEM156 (Homo sapiens) | 6480464 | TMEM156 protein affects the susceptibility to Doxorubicin | CTD | PMID:16217747 | ethyl methanesulfonate | decreases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in decreased expression of TMEM156 mRNA | CTD | PMID:23649840 | folic acid | increases expression | ISO | Tmem156 (Mus musculus) | 6480464 | Folic Acid results in increased expression of TMEM156 mRNA | CTD | PMID:25629700 | fulvestrant | multiple interactions | ISO | TMEM156 (Homo sapiens) | 6480464 | [bisphenol S co-treated with Fulvestrant] results in increased methylation of TMEM156 gene | CTD | PMID:31601247 | lipopolysaccharide | decreases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of TMEM156 mRNA | CTD | PMID:35811015 | lipopolysaccharide | multiple interactions | ISO | TMEM156 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | methyl methanesulfonate | decreases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of TMEM156 mRNA | CTD | PMID:23649840 | methylarsonic acid | multiple interactions | ISO | Tmem156 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TMEM156 mRNA | CTD | PMID:34876320 | methylisothiazolinone | increases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | 2-methyl-4-isothiazolin-3-one results in increased expression of TMEM156 mRNA | CTD | PMID:31629900 | methylparaben | decreases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | methylparaben results in decreased expression of TMEM156 mRNA | CTD | PMID:31745603 | mitomycin C | affects response to substance | ISO | TMEM156 (Homo sapiens) | 6480464 | TMEM156 protein affects the susceptibility to Mitomycin | CTD | PMID:16217747 | O-methyleugenol | increases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | methyleugenol results in increased expression of TMEM156 mRNA | CTD | PMID:32234424 | PD 0325901 | decreases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | mirdametinib results in decreased expression of TMEM156 mRNA | CTD | PMID:25119042 | PD 0325901 | multiple interactions | ISO | TMEM156 (Homo sapiens) | 6480464 | [mirdametinib co-treated with (+)-JQ1 compound] results in decreased expression of TMEM156 mRNA | CTD | PMID:25119042 | perfluorononanoic acid | increases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in increased expression of TMEM156 mRNA | CTD | PMID:32588087 | potassium chromate | decreases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of TMEM156 mRNA | CTD | PMID:22714537 | quercetin | increases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | Quercetin results in increased expression of TMEM156 mRNA | CTD | PMID:21632981 | resveratrol | multiple interactions | ISO | TMEM156 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of TMEM156 mRNA | CTD | PMID:23557933 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | TMEM156 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | silicon dioxide | increases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of TMEM156 mRNA and Silicon Dioxide results in increased expression of TMEM156 mRNA | CTD | PMID:25351596 and PMID:25895662 | sodium arsenate | multiple interactions | ISO | Tmem156 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TMEM156 mRNA | CTD | PMID:34876320 | sodium arsenite | increases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of TMEM156 mRNA | CTD | PMID:34032870 | sodium arsenite | multiple interactions | ISO | Tmem156 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TMEM156 mRNA | CTD | PMID:34876320 | sotorasib | multiple interactions | ISO | TMEM156 (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TMEM156 mRNA | CTD | PMID:36139627 | sulforaphane | increases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | sulforaphane results in increased expression of TMEM156 mRNA | CTD | PMID:31838189 | temozolomide | decreases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of TMEM156 mRNA | CTD | PMID:31758290 | testosterone | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TMEM156 mRNA | CTD | PMID:32741896 | trametinib | multiple interactions | ISO | TMEM156 (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TMEM156 mRNA | CTD | PMID:36139627 | triptonide | increases expression | ISO | Tmem156 (Mus musculus) | 6480464 | triptonide results in increased expression of TMEM156 mRNA | CTD | PMID:33045310 | valproic acid | decreases expression | ISO | TMEM156 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of TMEM156 mRNA | CTD | PMID:29154799 | vincaleukoblastine | affects response to substance | ISO | TMEM156 (Homo sapiens) | 6480464 | TMEM156 protein affects the susceptibility to Vinblastine | CTD | PMID:16217747 | |